Dysphonia. Dysphonia
Conditions
Interventions
Intervention 1: Intervention group: Treating with the supplement Dino® tablets containing vitamins B1 (thiamin), B6 (Pyridoxin), B12 (Cobalamin), and B9 (Folic acid) along with alpha lipoic acid at 10
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients older than 18 years of age Patients who performed thyroidectomy surgery regardless of its clinical indication Patients showing the complication of dysphonia after a 2-week follow-up after surgery Patients having consent to taking part in the study
Exclusion criteria
Exclusion criteria: Patients with known laryngeal nerve damage during operation or malignant nerve involvement Patients with a history of gastroesophageal reflux disease (GERD) Patients with previous neck surgery Patients who frequently experience hypoglycemia following use of antidiabetic agents Patients with known vocal cord dysfunction Patients with hearing or voice problems Patients with known allergy to any of the components of the product Patients younger than 18 years of age Pregnant and lactating women Patients unwilling to take part in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in the extent of dysphonia. Timepoint: Evaluation of dysphonia will be performed at the start of the study (before the intervention) and 2 weeks (14 days) after medication therapy. Method of measurement: Voice Handicap Index-10 questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDena Firouzabadi
Shiraz University of Medical Sciences
Outcome results
None listed